Bioorganic & Medicinal Chemistry Letters 2006-01-15

The identification of potent and selective imidazole-based inhibitors of B-Raf kinase.

Andrew K Takle, Murray J B Brown, Susannah Davies, David K Dean, Gerraint Francis, Alessandra Gaiba, Alex W Hird, Frank D King, Peter J Lovell, Antoinette Naylor, Alastair D Reith, Jon G Steadman, David M Wilson

Index: Bioorg. Med. Chem. Lett. 16(2) , 378-381, (2006)

Full Text: HTML

Abstract

A novel triarylimidazole derivative, SB-590885 (33), bearing a 2,3-dihydro-1H-inden-1-one oxime substituent has been identified as a potent and extremely selective inhibitor of B-Raf kinase.

Related Compounds

Related Articles:

Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ.

2011-06-23

[J. Med. Chem. 54 , 4219-4233, (2011)]

Novel imidazolyl and triazolyl substituted biphenyl compounds: synthesis and evaluation as nonsteroidal inhibitors of human 17alpha-hydroxylase-C17, 20-lyase (P450 17).

2000-06-01

[Bioorg. Med. Chem. 8(6) , 1245-52, (2000)]

Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.

2006-03-15

[Bioorg. Med. Chem. Lett. 16(6) , 1532-1536, (2006)]

Asymmetric Strecker-Type Reaction of alpha-Aryl Ketones. Synthesis of (S)-alphaM4CPG, (S)-MPPG, (S)-AIDA, and (S)-APICA, the Antagonists of Metabotropic Glutamate Receptors.

2001-01-01

[J. Org. Chem. 64(1) , 120-125, (1999)]

Enzymatic Baeyer-Villiger Oxidation of Benzo-Fused Ketones: Formation of Regiocomplementary Lactones. Rioz-Martinez A, et al.

[European J. Org. Chem. 2009(15) , 2526-2532, (2009)]

More Articles...